Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.017 | 0.7 |
mRNA | Rapamycin | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.7 |